Eotaxins. Contributing to the diversity of eosinophil recruitment and activation.

This invention relates to a novel design of decorative, detachable/attachable magnetic collar stay devices to be used on the collars of sports shirts. The magnetic portions of the device are arranged so that the top portion and bottom portion of the device have opposite polarities from each other. The bottom portion is enabled to receive collar stays of various lengths. The outward surface of the top portion has a relatively flat surface enabled for the affixing of a decorative element.

[1]  R. Breuer,et al.  Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. , 2001, American journal of respiratory cell and molecular biology.

[2]  L. J. Woods,et al.  Cutting Edge: Eotaxin Elicits Rapid Vesicular Transport-Mediated Release of Preformed IL-4 from Human Eosinophils1 , 2001, The Journal of Immunology.

[3]  M. Baggiolini,et al.  Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. , 2001, Blood.

[4]  L. Mazzucchelli,et al.  CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease. , 2001, Blood.

[5]  M. Baggiolini,et al.  The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.

[6]  F. Baroody,et al.  Cutting Edge: Expression of the C-C Chemokine Receptor CCR3 in Human Airway Epithelial Cells1 , 2001, The Journal of Immunology.

[7]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[8]  A. Knox,et al.  Regulation of TNF‐α‐induced eotaxin release from cultured human airway smooth muscle cells by β2‐agonists and corticosteroids , 2001 .

[9]  H. Sarau,et al.  Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration* , 2000, The Journal of Biological Chemistry.

[10]  M. Dorf,et al.  Astrocytes express functional chemokine receptors , 2000, Journal of Neuroimmunology.

[11]  J. Lötvall,et al.  Upregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoid , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  F. Levi-Schaffer,et al.  Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist1 , 2000, The Journal of Immunology.

[13]  Y. Kato,et al.  Chemokines induce eosinophil degranulation through CCR-3. , 2000, The Journal of allergy and clinical immunology.

[14]  M. Peck,et al.  A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.

[15]  Sha Quan,et al.  CXCR3 Expression and Activation of Eosinophils: Role of IFN-γ-Inducible Protein-10 and Monokine Induced by IFN-γ1 , 2000, The Journal of Immunology.

[16]  S. Stafford,et al.  Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. , 2000, Blood.

[17]  B. Nardelli,et al.  C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.

[18]  A. Luster,et al.  Structure and function of the murine chemokine receptor CXCR3 , 1999, European journal of immunology.

[19]  T. Suda,et al.  Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis. , 1999, Biochemical and biophysical research communications.

[20]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine (Eotaxin-3) That Is a Functional Ligand of CC Chemokine Receptor 3* , 1999, The Journal of Biological Chemistry.

[21]  M. Rothenberg,et al.  Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. , 1999, American journal of respiratory cell and molecular biology.

[22]  K. Bacon,et al.  Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. , 1999, Journal of immunology.

[23]  P. Brandtzaeg,et al.  Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. , 1999, Journal of immunology.

[24]  T. Nishi,et al.  A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. , 1999, Journal of immunology.

[25]  H. Ochi,et al.  T Helper Cell Type 2 Cytokine–Mediated Comitogenic Responses and Ccr3 Expression during Differentiation of Human Mast Cells in Vitro , 1999, The Journal of experimental medicine.

[26]  M. Rothenberg,et al.  CC Chemokine Receptor-3 Undergoes Prolonged Ligand-induced Internalization* , 1999, The Journal of Biological Chemistry.

[27]  E. De Clercq,et al.  CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. , 1999, Journal of immunology.

[28]  C. Schlüter,et al.  Genomic organization, sequence analysis and transcriptional regulation of the human MCP-4 chemokine gene (SCYA13) in dermal fibroblasts: a comparison to other eosinophilic beta-chemokines. , 1999, Biochemical and biophysical research communications.

[29]  T. Ishikawa,et al.  Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release. , 1999, Mediators of inflammation.

[30]  J. Demartino,et al.  Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors* , 1998, The Journal of Biological Chemistry.

[31]  A. Kapp,et al.  Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils , 1998, European journal of immunology.

[32]  A. Proudfoot,et al.  The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.

[33]  S. Kunkel,et al.  Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. , 1997, The Journal of clinical investigation.

[34]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[35]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[36]  S. Rankin,et al.  Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.

[37]  M. Baggiolini,et al.  Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.

[38]  J. Drazen,et al.  Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. , 1997, The Journal of clinical investigation.

[39]  J. Norgauer,et al.  Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. , 1996, Blood.

[40]  A. Kapp,et al.  Human eotaxin represents a potent activator of the respiratory burst of human eosinophils , 1996, European journal of immunology.

[41]  P. Bates.  Chemokine Receptors and HIV-1: An Attractive Pair? , 1996, Cell.

[42]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[43]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[44]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[45]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[46]  A. Dvorak,et al.  Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1. , 1995, American journal of respiratory cell and molecular biology.

[47]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[48]  P. Weller,et al.  Mechanisms of eosinophil recruitment. , 1993, American journal of respiratory cell and molecular biology.

[49]  G. Griffin,et al.  Human immunodeficiency virus infection of eosinophils in human bone marrow cultures , 1991, The Journal of experimental medicine.

[50]  D. Dorsky,et al.  Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120 , 1989, The Journal of experimental medicine.

[51]  K. Austen,et al.  AN EOSINOPHIL LEUKOCYTE CHEMOTACTIC FACTOR OF ANAPHYLAXIS , 1971, The Journal of experimental medicine.